BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7459232)

  • 1. Growth in vivo of l5178y-r murine leukaemic cells treated in vitro with cis-dichloro bis-(cyclopentylamine) platinum II.
    Szumiel I; Niepokojczycka E; Godlewska E
    Br J Cancer; 1981 Jan; 43(1):116-7. PubMed ID: 7459232
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of tumorigenicity with simultaneous changes in radiosensitivity and photosensitivity during in vitro growth of L5178Y murine lymphoma cells.
    Beer JZ; Budzicka E; Niepokojczycka E; Rosiek O; Szumiel I; Walicka M
    Cancer Res; 1983 Oct; 43(10):4736-42. PubMed ID: 6883332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo and in-vitro association between leukemic cells and marrow stromal cells: a murine model.
    Juneja HS; Lee S
    Leuk Res; 1988; 12(8):631-6. PubMed ID: 3184979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of growth of the L5178Y murine lymphoma by means of immunization with radiated L5178Y cells.
    Ramos-Damián M; Gómez-Estrada H; Acosta-Ruiz R; Díaz-Esquivel P; Vázquez-Escobosa C
    Arch Invest Med (Mex); 1982; 13(1):29-31. PubMed ID: 7065806
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of horse and fetal calf serum on the expression of tumor-associated antigen and tumorigenicity of L5178Y leukemia/lymphoma cells.
    Rabinovsky ED; Yang TJ
    Leuk Res; 1986; 10(11):1331-40. PubMed ID: 3796035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantability and sensitivity to natural killer cells of aclarubicin-resistant murine lymphoma.
    Sugimoto Y; Hirakawa Y; Tanaka N; Tahara M; Sato I; Nishimura T; Suzuki H; Tanaka N
    Cancer Res; 1986 Nov; 46(11):5646-8. PubMed ID: 3463416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of two strains of L5178Y cells to cis-dichlorobis(cyclopentylamine)platinum(II). I. Cross-sensitivity to cis-PAD and UV light.
    Szumiel I
    Chem Biol Interact; 1979 Jan; 24(1):51-72. PubMed ID: 428002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between 5-fluoro-2'-deoxyuridine and 5-fluorouridine in their cytotoxic effect on growth of murine lymphoma L5178Y cells in in vivo and in vitro systems.
    Kanzawa F; Hoshi A; Kuretani K
    Eur J Cancer (1965); 1980 Aug; 16(8):1087-92. PubMed ID: 6449368
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of misonidazole on the radiosensitivity and repair of potentially lethal damage of L5178Y ascites tumor cells.
    Nakagawa K; Tsunemoto H; Watanabe I
    Eur J Cancer Clin Oncol; 1983 Apr; 19(4):527-32. PubMed ID: 6683187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of asparaginase- and guinea pig complement-resistant subline of murine lymphoblastic leukemia L5178y cells.
    Yang TJ; Gawlak S
    Oncology; 1984; 41(6):446-51. PubMed ID: 6390288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytotoxic and mutagenic effects of UVA radiation on L5178Y mouse lymphoma cells.
    Hitchins VM; Withrow TJ; Olvey KM; Harleston BA; Ellingson OL; Bostrom RG
    Photochem Photobiol; 1986 Jul; 44(1):53-7. PubMed ID: 3749293
    [No Abstract]   [Full Text] [Related]  

  • 12. Dependence on exogenous methionine of rat sarcoma and murine leukemia cells in culture.
    Koziorowska J; Pieńkowska K; Tautt J
    Arch Immunol Ther Exp (Warsz); 1980; 28(5):709-16. PubMed ID: 7212978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo lysis of L5178Y cells in the establishment of the tumor-dormant state in DBA/2 mice.
    Wheelock EF; Weinhold KJ; Ingenito GG; Goldstein LT
    J Immunol; 1980 Apr; 124(4):1642-7. PubMed ID: 7365237
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-activity relationship of polyamine derivatives of 1,3-dichloroacetone-thiosemicarbazone: induction of metastases and increase in sialylation of murine lymphoma L5178Y-R cells.
    Wojewodzka M; Bartoszewicz Z; Jaworska A; Lukasiewicz A; Rosiek O
    Chem Biol Interact; 1990; 74(3):221-31. PubMed ID: 2347002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition of lymphoblast leukemia cells by amplifying factors of glucocorticoid actions.
    Katunuma N; Kido H; Tomihara Y
    Adv Enzyme Regul; 1980; 18():87-96. PubMed ID: 7004131
    [No Abstract]   [Full Text] [Related]  

  • 16. The L5178Y S/S murine leukemic lymphoblast: a radiosensitive, malignant cell of stable karyotype.
    Rutledge MH; Lett JT
    Radiat Res; 1980 Feb; 81(2):282-91. PubMed ID: 7360885
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer therapy with chemically modified enzymes. II. The therapeutic effectiveness of arginase, and arginase modified by the covalent attachment of polyethylene glycol, on the taper liver tumor and the L5178Y murine leukemia.
    Savoca KV; Davis FF; van Es T; McCoy JR; Palczuk NC
    Cancer Biochem Biophys; 1984 Sep; 7(3):261-8. PubMed ID: 6488153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local anaesthetics as hypoxic radiosensitizers, oxic radioprotectors and potentiators of hyperthermic killing in mammalian cells.
    Yau TM; Kim SC
    Br J Radiol; 1980 Jul; 53(631):687-92. PubMed ID: 7426891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic changes in the murine leukemia L5178Y cells treated with antibodies in the absence of complement activity.
    Yang TJ; Haddad-Khairallah L; Wachtel A
    Exp Mol Pathol; 1981 Aug; 35(1):137-52. PubMed ID: 6166498
    [No Abstract]   [Full Text] [Related]  

  • 20. Elimination of L5178Y cells from tumor-dormant DBA/2 mice by specific active immunotherapy.
    Marsili MA; Robinson MK; Truitt GA; Wheelock EF
    Cancer Res; 1983 Jan; 43(1):15-21. PubMed ID: 6600159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.